T-cell immunotherapy with a chimeric receptor against CD38 is effective in eradicating chemotherapy-resistant B-cell lymphoma cells overexpressing survivin induced by BMI-1

J. Bhattacharyya, K. Mihara, A. Kitanaka, K. Yanagihara, T. Kubo, Y. Takei, A. Kimura, Y. Takihara

Research output: Contribution to journalLetterpeer-review

7 Citations (Scopus)
Original languageEnglish
Article numbere75
JournalBlood cancer journal
Issue number6
Publication statusPublished - 29-06-2012
Externally publishedYes

All Science Journal Classification (ASJC) codes

  • Hematology
  • Oncology

Cite this